Answers are grounded in this paper and cite their sources.
Retrospective study shows high patency and zero recurrent bleeding after mesocaval shunting in chronic portomesenteric thrombosis, indicating endovascular feasibility.
The purpose of this study is to investigate the technical efficacy and safety profile of mesocaval shunt placement in patients with chronic portomesenteric thrombosis and variceal mesenteric inflow. This is a single-arm, single-center retrospective study examining patients who had mesocaval shunts placed with variceal mesenteric inflow (July 2013-July 2023). Procedural outcomes including technical success and 30-day major adverse events were recorded. Followup data, including clinical symptom management, patency, and revisions were also recorded. Patients with chronic portomesenteric thrombosis and refractory symptoms of portal hypertension were included. All shunts were constructed using a balloon-expandable covered stent to bridge the vessels (mesenteric varix to vena cava) with anchoring self-expanding bare-metal stents, extending across both ends of the shunt. Three shunts were created using a combined endovascular and percutaneous approach. All patients received long-term anticoagulation as well as peri- and post-operative antibiotics. Four subjects were identified - 75% female, mean age 51.3 (range: 30-62). Three patients had a diagnosed underlying coagulopathy, three had clinically significant variceal hemorrhage, and two had an occluded or failed intrahepatic shunt. Mean followup time was 54 months (4 months to 10 years). There was a 100% technical success rate. There were no immediate procedure related complications, including abdominal hemorrhage, infection, heart failure, and uncorrectable hepatic encephalopathy. There were no episodes of variceal hemorrhage across the length of follow up. Shunts demonstrate primary, primary-assisted, and secondary patency rates of 50%, 100%, and 100% respectively. Two shunts underwent revision to maintain patency and one was revised due to concern for stent migration. Endovascular mesocaval shunting is technically feasible and relatively safe in patients with mesenteric varices in the setting of chronic portomesenteric thrombosis. Continued imaging surveillance is crucial for prompting intervention prior to the recurrence of symptoms.
No takes yet. Share an insight, caveat, or question.
Gulamali et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: